share_log

Virpax Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Singh Vanila

Virpax製藥 | 4:持股變動聲明-董事 Singh Vanila

美股SEC公告 ·  02/01 05:28

牛牛AI助理已提取核心訊息

In a recent transaction, Vanila Singh, associated with Virpax Pharmaceuticals Inc. [VRPX], executed a stock transaction on January 29, 2024. The specific details regarding the nature of the shares, the number of shares transacted, the transaction price, and the resulting ownership stake after the transaction were not disclosed. This event may be of interest to investors following Virpax Pharmaceuticals' stock activity.
In a recent transaction, Vanila Singh, associated with Virpax Pharmaceuticals Inc. [VRPX], executed a stock transaction on January 29, 2024. The specific details regarding the nature of the shares, the number of shares transacted, the transaction price, and the resulting ownership stake after the transaction were not disclosed. This event may be of interest to investors following Virpax Pharmaceuticals' stock activity.
在最近的一筆交易中,與Virpax Pharmicals Inc. [VRPX] 相關的瓦尼拉·辛格於2024年1月29日執行了一筆股票交易。有關股票性質、交易的股票數量、交易價格以及交易後由此產生的所有權的具體細節尚未披露。關注Virpax Pharmaceuticals股票活動的投資者可能會對這一事件感興趣。
在最近的一筆交易中,與Virpax Pharmicals Inc. [VRPX] 相關的瓦尼拉·辛格於2024年1月29日執行了一筆股票交易。有關股票性質、交易的股票數量、交易價格以及交易後由此產生的所有權的具體細節尚未披露。關注Virpax Pharmaceuticals股票活動的投資者可能會對這一事件感興趣。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生,只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。